Session » T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Date: Monday, November 14, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM: Abstract Number: 1727

BATF Represses BIM Expression to Sustain the T Cell Anergy Program

1:00PM-3:00PM: Abstract Number: 1747

Changes in the Number and Phenotype of Citrullinated-Antigen Specific T Cells Correlate with Treatment Outcome in Seropositive Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1738

Characterization of T Cell Subsets in the Synovium of Chronic Inflammatory Joint Diseases

1:00PM-3:00PM: Abstract Number: 1740

Chronic Inflammation in Patients with Rheumatoid Arthritis or Spondyloarthritis Alters Regulatory T Cells Identity

1:00PM-3:00PM: Abstract Number: 1735

Clonally Expanded Cytotoxic CD8+ T Cells Recognize Citrullinated Antigens in ACPA+ Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1748

Deep Immune Profiling of Cytotoxic T Cells (CTL) from Patients with Ankylosing Spondylitis Revealed a Subset of CTL Co-Expressing PD-1 and TIGIT That Resists Immune Exhaustion

1:00PM-3:00PM: Abstract Number: 1745

Effects of Excess IL-18 in Mixed Inflammatory Environments

1:00PM-3:00PM: Abstract Number: 1733

Granzyme K Elicits a New Pathway for Complement Activation in RA Synovium

1:00PM-3:00PM: Abstract Number: 1743

Identification of Immune Cell Types in the Peripheral Blood of Rheumatoid Arthritis Patients Associated with Susceptibility and Response to Treatment

1:00PM-3:00PM: Abstract Number: 1734

Identification of Sjögren’s Disease-Associated T Cell Receptors Through Deep Sequencing and Single-Cell Transcriptomics

1:00PM-3:00PM: Abstract Number: 1736

IL-23 Signaling Induces Autoimmune Disease Genes in Mucosal-Associated Invariant T Cells

1:00PM-3:00PM: Abstract Number: 1744

Immune Responses to mRNA Vaccines Against SARS-CoV-2 in Patients with Immune-mediated Inflammatory Rheumatic Diseases

1:00PM-3:00PM: Abstract Number: 1737

In Vitro Response to Disease Modifying Antirheumatic Drugs Link Molecular Drug Target with Synovial Transcriptional Signature

1:00PM-3:00PM: Abstract Number: 1746

Increased CD39+FoxP3+CD4+ Regulatory T Cells in Early Rheumatoid Arthritis Provide a Slot for Prompt Initiation of Methotrexate and Serve as Early Biomarkers of Clinical Response

1:00PM-3:00PM: Abstract Number: 1728

Increased Frequency of Highly Differentiated T Effector Memory Cells Re-expressing CD45RA (Temra) and Cytomegalovirus Seropositivity Are Associated with Persistent Disease Specifically Refractory to Anti-TNF Therapy in Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1749

Mass Spectrometry-Based HLA Peptidomics Analysis Reveals Both Expected and Novel Citrullinated Antigen Targets in Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1741

Mutated Nod2 Controls T Cell Function and Promotes Uveitis in a Blau Syndrome Mouse Model

1:00PM-3:00PM: Abstract Number: 1732

Novel Human Class II MHC Tetramers Detect Rare, Self-Reactive CD4+ T Cells Relevant to Mixed Connective Tissue Disease

1:00PM-3:00PM: Abstract Number: 1742

Shared Epitope Allomorphs Directly Influence Antigen-specific T-cell Responses in RA

1:00PM-3:00PM: Abstract Number: 1739

Single-Cell Characterization of the TCR Repertoire Across Tissue and Blood in Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1729

SLAMF4+ CCR5+ Effector Memory CD4+ T Cells Are Polyfunctional, Resistant to Exhaustion, and Expanded in Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1731

Systemic Sclerosis-Associated Class II HLA Alleles Restrict the Diversity of the CDR3 and the T Cell Receptor Repertoire in African American Patients

1:00PM-3:00PM: Abstract Number: 1730

T Cell-Macrophage Interactions Play a Critical Role in a Mouse Model of Histidyl-tRNA Synthetase-Induced Myositis

« View all sessions from this meeting